Key Takeaways
- Strong quarter, broad-based growth: Revenue grew 39% YoY, driven by double-digit volume growth, price recovery, and favorable forex, with Europe nearly doubling.
- Margins structurally improved: Gross margin expanded to 34.9% in Q3 (35% in 9M), and management sees 35% as sustainable for FY27, with potential for further upside.
- Working capital transformed: Working capital days halved from 98 to 70 days, driven by demand normalization, supplier confidence, and disciplined European customer payments.
- Pricing cycle turning, slowly: Prices are moving up after the destocking trough, though the pace is gradual; management notes percentage margins are better than pre-COVID levels.
- What to watch next quarter: Whether the 15-20% FY27 revenue growth guidance holds as Q4 base effect kicks in, and any signal on the pace of price recovery.
Revenue Growth & Regional Dynamics
- Volume-led growth: Agrochemical volumes grew ~15% YoY, non-agrochemical ~14% YoY, supported by ability to supply seasonal products on time and good quality.
- Price and mix tailwind: Combined price and product mix impact contributed 11.6% to revenue growth, as pipeline stocks have dried up and normalization is underway.
- Forex benefit: Favorable currency movements added 12.6% to revenue growth in Q3.
- Europe nearly doubled: Driven by good climate, strong demand, new dealer additions, better market access, and geographic expansion within countries; growth was demand-driven, not one-off restocking.
- NAFTA declined: Agrochemical segment de-grew in NAFTA, partly attributed to heavy unpredictable climate conditions; management stated tariffs are not a factor since registered agrochemicals are not freely tradable.
- No new regions planned: Europe, NAFTA, and LATAM constitute ~80-90% of the global agrochemical market; focus remains on deeper penetration in existing regions.
Bubna: "We have passed through a very bad time about 2 years back when there was excess liquidity and abundance of stocks in the pipeline. Those have dried up. And as the things are getting normalized, the prices are also moving. The speed is less, but it is moving up."
Margin Trajectory & Profitability
- Gross margin expansion: Gross margins expanded 220 bps YoY to 34.9% in Q3, and 500 bps to 35% in 9M, driven by input cost stabilization and improved product mix.
- FY26 gross margin: Expected to remain around 35% for the full year.
- FY27 gross margin: Management sees 35% as sustainable and stated it "may go up still further."
- EBITDA margin guidance: On track for 18-20% in FY26, with the same range guided for FY27.
- Sourcing cost advantage: While price realizations remain below pre-COVID levels, sourcing costs have also fallen considerably; in percentage terms, Sharda is better off than pre-COVID with better margins.
- Procurement trend: Both sourcing and selling prices are rising gradually, and margins are improving for Sharda.
Working Capital & Balance Sheet
- Working capital days halved: Reduced from 98 days as of March 2025 to 70 days, a 48-day improvement.
- Drivers of improvement: Consistent demand increase, supplier confidence in Sharda's credibility leading to extended credits, customers paying on time, and European region being the most disciplined for payments, sometimes paying before time.
- Highest-ever PAT: Company achieved its highest-ever annual PAT in 9M FY26.
- Interim dividend: Board declared an interim dividend of ₹6 per share, and management indicated the company is looking into increasing dividends further.
- Acquisitions off the table: Management stated the company is not looking into acquisitions.
Product Registrations: The Moat & The Uncertainty
- Registration count: Total product registrations stood at 3,004 as of 31st December 2025, with 1,076 applications in the approval stage.
- Timeline unpredictability: Management declined to give any timeline for pending approvals, stating a registration may take 1-2 years or 6-7 years due to government authority uncertainties.
- Tariff insulation: Agrochemical products are not impacted by tariffs because they require registration, involving huge investment in an intangible asset; very few companies commit to this.
- Sourcing lock-in: Products and manufacturing plants are registered together, making it difficult to switch sources; this limits the ability to diversify sourcing away from China quickly.
Bubna: "To give you an example, a registration may be obtained in 1 year or 2 years, and the same registration can take 6 to 7 years because of the uncertainties. The government authorities keep..."
China Sourcing & Competitive Dynamics
- China export rebate policy: Management declined to comment on China rolling back export incentives, stating the Chinese government is not transparent, information is not available to foreigners, and "it doesn't affect us."
- China tightening exports: When asked about reports of China tightening agrochemical exports, management said they were hearing it for the first time and stated "we are not impacted at all."
- Sourcing diversification constrained: While asked about hedging China reliance by sourcing from India or other countries, management explained that registration constraints (product and plant registered together) make switching sources non-trivial.
Bubna: "The only thing I can say that China does give some incentives to the Chinese citizens for export. Now how much and what is their policy and what is the variation, it's very difficult to gather and it doesn't affect us. Do you understand?"
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | Around 15% to 20% total revenue growth | FY27 |
| Volume growth | Confident 15% volume growth is achievable | FY27 |
| Gross margin | Sustainable at 35%; may go up further | FY27 |
| EBITDA margin | In range of 18% to 20% | FY27 |
| Capex | In range of ₹450 crores to ₹500 crores | FY27 |
| Tax rate | Annual tax rate in range of 18% to 20% | Ongoing |
| Q4 momentum | Expect similar volume and pricing growth to continue | Q4 FY26 |
Key Metrics
| Metric | Q3 FY26 |
|---|---|
| Revenue | ₹1,289 cr, +39% YoY |
| Agrochemical segment revenue | ₹1,141 cr, +48% YoY |
| Non-agrochemical segment revenue | ₹148 cr, -8.1% YoY |
| Overall volume growth | 14% YoY |
| Agrochemical segment volume growth | ~15% YoY |
| Gross margin | 34.9%, +220 bps YoY |
| EBITDA | ₹245.5 cr, +59% YoY |
| EBITDA margin | 19.1% |
| PAT | ₹145.1 cr, +366% YoY |
| Forex impact | Loss of ₹4.53 cr, on foreign currency payable realignment |
| Revenue growth bridge | 38.7% total growth: volume +14.4%, forex +12.6%, price/mix +11.6% |
| Working capital days | 70 days, improved 48 days vs March 2025 and 28 days vs Dec 2024 |
| Cash and bank liquid investments | ₹826 cr as on 31 Dec 2025 |
| Capex (9M FY26) | ₹399 cr |
| Planned capex (FY26) | ₹500 cr |
| Total product registrations | 3,004 as on 31 Dec 2025 |
| Registration applications in pipeline | 1,076 |
| Interim dividend | ₹6 per share |
| FY26 revenue growth guidance | 20%, maintained |
| FY26 EBITDA margin guidance | 18% to 20% |
| FY27 volume growth expectation | 15%, confident of achieving |
| FY27 capex guidance | ₹450 cr to ₹500 cr |
| FY27 revenue growth expectation | 15% to 20% |
| Top 10 products revenue share | ~43% |
| Top 10 dealers revenue share | ~16% to 17%, similar to last year |